Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

2HFG

Crystal structure of hBR3 bound to CB3s-Fab

2HFG の概要
エントリーDOI10.2210/pdb2hfg/pdb
関連するPDBエントリー2hff
分子名称CB3s Fab light chain (kappa), CB3s Fab heavy chain, Tumor necrosis factor receptor superfamily member 13C, ... (4 entities in total)
機能のキーワードfab fragment, tnfrsf, antibody-receptor complex, crd, immune system
由来する生物種Homo sapiens (human)
詳細
細胞内の位置Membrane; Single-pass type III membrane protein (Probable): Q96RJ3
タンパク質・核酸の鎖数3
化学式量合計52988.36
構造登録者
Hymowitz, S.G. (登録日: 2006-06-23, 公開日: 2006-11-07, 最終更新日: 2024-10-30)
主引用文献Lee, C.V.,Hymowitz, S.G.,Wallweber, H.J.,Gordon, N.C.,Billeci, K.L.,Tsai, S.P.,Compaan, D.M.,Yin, J.,Gong, Q.,Kelley, R.F.,Deforge, L.E.,Martin, F.,Starovasnik, M.A.,Fuh, G.
Synthetic anti-BR3 antibodies that mimic BAFF binding and target both human and murine B cells.
Blood, 108:3103-3111, 2006
Cited by
PubMed Abstract: BR3, which is expressed on all mature B cells, is a specific receptor for the B-cell survival and maturation factor BAFF (B-cell-activating factor belonging to the tumor necrosis factor [TNF] family). In order to investigate the consequences of targeting BR3 in murine models and to assess the potential of BR3 antibodies as human therapeutics, synthetic antibody phage libraries were employed to identify BAFF-blocking antibodies cross-reactive to murine and human BR3, which share 52% identity in their extracellular domains. We found an antibody, CB1, which exhibits muM affinity for murine BR3 and very weak affinity for the human receptor. CB3s, an affinity-matured variant of CB1, has sub-nM affinity for BR3 from both species. Alanine scanning and crystallographic structural analysis of the CB3s/BR3 complex reveal that CB3s mimics BAFF by interacting with a similar region of the BR3 surface. Despite this similarity in binding epitopes, CB1 variants antagonize BAFF-dependent human B-cell proliferation in vitro and are effective at reducing murine B-cell populations in vivo, showing significant promise as therapeutics for human B-cell-mediated diseases.
PubMed: 16840730
DOI: 10.1182/blood-2006-03-011031
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.61 Å)
構造検証レポート
Validation report summary of 2hfg
検証レポート(詳細版)ダウンロードをダウンロード

227561

件を2024-11-20に公開中

PDB statisticsPDBj update infoContact PDBjnumon